KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Crescent Capital BDC (CCAP) EBT (2021 - 2025)

Historic EBT for Crescent Capital BDC (CCAP) over the last 5 years, with Q3 2025 value amounting to $17.2 million.

  • Crescent Capital BDC's EBT fell 2886.96% to $17.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $72.2 million, marking a year-over-year decrease of 2252.66%. This contributed to the annual value of $90.6 million for FY2024, which is 803.84% up from last year.
  • Per Crescent Capital BDC's latest filing, its EBT stood at $17.2 million for Q3 2025, which was down 2886.96% from $17.3 million recorded in Q2 2025.
  • In the past 5 years, Crescent Capital BDC's EBT ranged from a high of $24.2 million in Q3 2024 and a low of $12.3 million during Q1 2022
  • Moreover, its 5-year median value for EBT was $17.3 million (2025), whereas its average is $18.4 million.
  • As far as peak fluctuations go, Crescent Capital BDC's EBT surged by 4395.09% in 2023, and later plummeted by 2886.96% in 2025.
  • Over the past 5 years, Crescent Capital BDC's EBT (Quarter) stood at $13.3 million in 2021, then increased by 21.47% to $16.2 million in 2022, then soared by 43.05% to $23.2 million in 2023, then dropped by 11.2% to $20.6 million in 2024, then decreased by 16.35% to $17.2 million in 2025.
  • Its EBT stands at $17.2 million for Q3 2025, versus $17.3 million for Q2 2025 and $17.1 million for Q1 2025.